PPH
VanEck Pharmaceutical ETF
Price Chart
Latest Quote
$114.63
-0.16 (-0.14%)
Current Price
| Previous Close | $114.79 |
| Open | $114.36 |
| Day High | $115.29 |
| Day Low | $114.20 |
| Volume | 288,980 |
Fund Information
| Quarterly Dividend / Yield | N/A / 1.99% |
| Shares Outstanding | 11.55M |
| Net Assets | $1.02B |
| Expense Ratio | 0.36% |
| Category | Health |
| Fund Family | VanEck |
| Net Asset Value | $114.77 |
| Premium/Discount | -0.12% |
| Quarterly Dividend Yield | 1.99% |
| P/E Ratio | 26.20 |
| Exchange | NGM |
đ ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
| SMA20 | $111.88 |
| SMA50 | $112.26 |
| SMA200 | $106.84 |
| RSI | 65.21 |
| ATR | 2.0429 |
| Rel Volume | 0.76 |
Performance History
| Week | -1.47% |
| Month | +3.16% |
| Quarter | +1.40% |
| 6 Months | +15.98% |
| YTD | +12.43% |
| Year | +26.54% |
| 3 Years | +56.38% |
| 5 Years | +72.11% |
| 10 Years | +164.20% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-27 | $114.63 | 289,200 |
| 2026-10-26 | $114.79 | 259,200 |
| 2026-10-23 | $114.93 | 229,100 |
| 2026-10-22 | $117.04 | 507,500 |
| 2026-10-21 | $115.58 | 189,400 |
| 2026-10-20 | $116.34 | 601,700 |
| 2026-10-19 | $113.48 | 786,900 |
| 2026-10-16 | $114.41 | 187,300 |
| 2026-10-15 | $114.11 | 435,500 |
| 2026-10-14 | $112.13 | 657,400 |
| 2026-10-13 | $109.23 | 346,700 |
| 2026-10-12 | $110.70 | 442,200 |
| 2026-10-09 | $110.49 | 273,400 |
| 2026-10-08 | $109.18 | 490,900 |
| 2026-10-07 | $109.49 | 238,600 |
| 2026-10-06 | $108.17 | 222,400 |
| 2026-10-05 | $107.61 | 294,300 |
| 2026-10-02 | $108.06 | 272,500 |
| 2026-10-01 | $108.14 | 365,900 |
| 2026-09-30 | $109.11 | 544,700 |
| 2026-09-29 | $110.74 | 520,100 |
| 2026-09-28 | $111.11 | 499,700 |
About VanEck Pharmaceutical ETF
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
đ° Latest News
No news articles available at the moment. Check back later for updates on PPH.
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.